Clincosm LogoSign in Get a demo

respiratory tract neoplasms

Showing 1 - 17 of 17
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lung Cancer, Multiple Pulmonary Nodules, Lung Tumors Trial in Orlando, Rochester, Pinehurst (Ion Endoluminal System)

Not yet recruiting
  • Lung Cancer
  • +8 more
  • Ion Endoluminal System
  • Orlando, Florida
  • +2 more
Aug 16, 2023

NSCLC, NSCLC, Carcinoma, Bronchogenic Trial in Worldwide (Furmonertinib)

Recruiting
  • Non-Small Cell Lung Cancer
  • +14 more
  • Glendale, California
  • +12 more
Feb 2, 2023

NSCLC, NSCLC, Carcinoma, Bronchogenic Trial in United States (furmonertinib 240 mg, furmonertinib 160 mg, platinum-based chemo)

Recruiting
  • Non-Small Cell Lung Cancer
  • +13 more
  • furmonertinib 240 mg
  • +2 more
  • Yuma, Arizona
  • +37 more
Dec 14, 2022

RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Worldwide

Active, not recruiting
  • RET-altered Non Small Cell Lung Cancer
  • +39 more
  • pralsetinib (BLU-667)
  • Phoenix, Arizona
  • +65 more
Nov 10, 2022

Lung Tumors, NSCLC, Respiratory Tract Tumors Trial in Worldwide (BLU-945, osimertinib)

Recruiting
  • Lung Neoplasms
  • +23 more
  • La Jolla, California
  • +35 more
Oct 6, 2022

Tumors, Colorectal Tumors, Melanoma Trial in United States (Alectinib)

Terminated
  • Neoplasms
  • +27 more
  • Culver City, California
  • +28 more
Jul 25, 2022

Lung Tumor, NSCLC, Respiratory Tract Tumors Trial in United States (BLU-701, osimertinib, carboplatin)

Recruiting
  • Lung Neoplasm
  • +26 more
  • Boston, Massachusetts
  • +6 more
Jun 23, 2022

Tumors, Tumors, Glandular and Epithelial, Tumors by Histologic Type Trial in San Antonio (Entinostat, Placebo)

Completed
  • Neoplasms
  • +14 more
  • San Antonio, Texas
    The START Center for Cancer Care
Apr 21, 2022

Lung Tumor Malignant, NSCLC, Respiratory Tract Tumors Trial in United States (BLU-451)

Recruiting
  • Lung Neoplasm Malignant
  • +18 more
  • Fairfax, Virginia
    New Experimental Therapeutics of Virginia (NEXT Oncology)
Mar 29, 2022

Tumors, Tumors, Glandular and Epithelial, Tumors by Histologic Type Trial in San Antonio (Entinostat, Pembrolizumab)

Completed
  • Neoplasms
  • +13 more
  • San Antonio, Texas
    The START Center for Cancer Care
Jan 24, 2022

Pralsetinib to Best Available Therapy in RET-Fusion Positive

Enrolling by invitation
  • RET-fusion Non Small Cell Lung Cancer
  • +16 more
    • New York, New York
    • +2 more
    Aug 9, 2021

    NSCLC, Lung Tumors, Respiratory Tract Tumors Trial in Australia, Canada (Low dose CT)

    Active, not recruiting
    • Non-small Cell Lung Cancer
    • +8 more
    • Low dose CT
    • Sydney, New South Wales, Australia
    • +5 more
    Jul 15, 2021

    Lung Tumors, Respiratory Tract Tumors Trial in Calgary, Edmonton (Computed Tomography, Active smokers - Smoking cessation arm,

    Active, not recruiting
    • Lung Neoplasms
    • Respiratory Tract Neoplasms
    • Computed Tomography
    • +2 more
    • Calgary, Alberta, Canada
    • +1 more
    Mar 4, 2021

    Stage IV, NSCLC, Lung Tumors, Bronchial Tumors Trial in Italy (Carboplatin, Gemcitabine, Pemetrexed)

    Recruiting
    • Stage IV, NSCLC
    • +8 more
    • Meldola, Forlì, Italy
    • +27 more
    Nov 3, 2020

    Lung Tumors, NSCLC, Respiratory Tract Tumors Trial in Shanghai (SHR-1210, Carboplatin, Pemetrexed)

    Completed
    • Lung Neoplasms
    • +8 more
    • SHR-1210
    • +2 more
    • Shanghai, Shanghai, China
      Tongji University, Shanghai Pulmonary Hospital
    Jun 7, 2020

    Carcinoma, Non-Small Cell-Lung, Lung Tumors, Lung Cancer Trial in Worldwide (AV-299 + gefitinib, Gefitinib)

    Completed
    • Carcinoma, Non-Small Cell-Lung
    • +3 more
    • Shatin N.T., Hong Kong
    • +25 more
    Apr 6, 2015

    Respiratory Tract Tumors, Thymic Tumors, Pancreatic Tumors Trial in Naples (Octreotide-LAR)

    Completed
    • Respiratory Tract Neoplasms
    • +4 more
    • Naples, Italy
      University Federico II of Naples
    Oct 6, 2009